176 related articles for article (PubMed ID: 33322953)
1. New potent steroid sulphatase inhibitors based on 6-(1-phenyl-1
Ciupak O; Daśko M; Biernacki K; Rachon J; Masłyk M; Kubiński K; Martyna A; Demkowicz S
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):238-247. PubMed ID: 33322953
[TBL] [Abstract][Full Text] [Related]
2. Design and synthesis of 3-benzylaminocoumarin-7-O-sulfamate derivatives as steroid sulfatase inhibitors.
Hng Y; Lin MH; Lin TS; Liu IC; Lin IC; Lu YL; Chang CN; Chiu PF; Tsai KC; Chen MJ; Liang PH
Bioorg Chem; 2020 Mar; 96():103618. PubMed ID: 32059152
[TBL] [Abstract][Full Text] [Related]
3. New potent STS inhibitors based on fluorinated 4-(1-phenyl-1
Daśko M; Demkowicz S; Rachon J; Biernacki K; Aszyk J; Kozak W; Masłyk M; Kubiński K
J Asian Nat Prod Res; 2020 Nov; 22(11):1037-1044. PubMed ID: 31773975
[TBL] [Abstract][Full Text] [Related]
4. Bicyclic derivatives of the potent dual aromatase-steroid sulfatase inhibitor 2-bromo-4-{[(4-cyanophenyl)(4h-1,2,4-triazol-4-yl)amino]methyl}phenylsulfamate: synthesis, SAR, crystal structure, and in vitro and in vivo activities.
Wood PM; Woo LW; Labrosse JR; Thomas MP; Mahon MF; Chander SK; Purohit A; Reed MJ; Potter BV
ChemMedChem; 2010 Sep; 5(9):1577-93. PubMed ID: 20632362
[TBL] [Abstract][Full Text] [Related]
5. Recent progress in the development of steroid sulphatase inhibitors - examples of the novel and most promising compounds from the last decade.
Daśko M; Demkowicz S; Biernacki K; Ciupak O; Kozak W; Masłyk M; Rachon J
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1163-1184. PubMed ID: 32363947
[TBL] [Abstract][Full Text] [Related]
6. Steroid sulphatase inhibitors for breast cancer therapy.
Purohit A; Woo LW; Chander SK; Newman SP; Ireson C; Ho Y; Grasso A; Leese MP; Potter BV; Reed MJ
J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):423-32. PubMed ID: 14623540
[TBL] [Abstract][Full Text] [Related]
7. Development of Sulfamoylated 4-(1-Phenyl-1
Biernacki K; Ciupak O; Daśko M; Rachon J; Kozak W; Rak J; Kubiński K; Masłyk M; Martyna A; Śliwka-Kaszyńska M; Wietrzyk J; Świtalska M; Nocentini A; Supuran CT; Demkowicz S
J Med Chem; 2022 Mar; 65(6):5044-5056. PubMed ID: 35235747
[TBL] [Abstract][Full Text] [Related]
8. Development of steroid sulfatase inhibitors.
Woo LW; Purohit A; Potter BV
Mol Cell Endocrinol; 2011 Jul; 340(2):175-85. PubMed ID: 21238537
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationship for the first-in-class clinical steroid sulfatase inhibitor Irosustat (STX64, BN83495).
Woo LW; Ganeshapillai D; Thomas MP; Sutcliffe OB; Malini B; Mahon MF; Purohit A; Potter BV
ChemMedChem; 2011 Nov; 6(11):2019-34. PubMed ID: 21990014
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and in vitro evaluation of piperazinyl-ureido sulfamates as steroid sulfatase inhibitors.
Moi D; Foster PA; Rimmer LG; Jaffri A; Deplano A; Balboni G; Onnis V; Potter BVL
Eur J Med Chem; 2019 Nov; 182():111614. PubMed ID: 31422224
[TBL] [Abstract][Full Text] [Related]
11. Development of novel steroid sulfatase inhibitors. I. Synthesis and biological evaluation of biphenyl-4-O-sulfamates.
Okada M; Nakagawa T; Iwashita S; Takegawa S; Fujii T; Koizumi N
J Steroid Biochem Mol Biol; 2003 Nov; 87(2-3):141-8. PubMed ID: 14672734
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and biological evaluation of new arylamide derivatives possessing sulfonate or sulfamate moieties as steroid sulfatase enzyme inhibitors.
El-Gamal MI; Semreen MH; Foster PA; Potter BV
Bioorg Med Chem; 2016 Jun; 24(12):2762-7. PubMed ID: 27143133
[TBL] [Abstract][Full Text] [Related]
13. A new series of aryl sulfamate derivatives: Design, synthesis, and biological evaluation.
El-Gamal MI; Zaraei SO; Foster PA; Anbar HS; El-Gamal R; El-Awady R; Potter BVL
Bioorg Med Chem; 2020 Apr; 28(8):115406. PubMed ID: 32173116
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of N-acylated tyramine sulfamates containing C-F bonds as steroid sulfatase inhibitors.
Daśko M; Rachon J; Masłyk M; Kubiński K; Demkowicz S
Chem Biol Drug Des; 2017 Jul; 90(1):156-161. PubMed ID: 28032462
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of bicoumarin thiophosphate derivatives as steroid sulfatase inhibitors.
Demkowicz S; Kozak W; Daśko M; Masłyk M; Gielniewski B; Rachon J
Eur J Med Chem; 2015 Aug; 101():358-66. PubMed ID: 26163883
[TBL] [Abstract][Full Text] [Related]
16. 2-difluoromethyloestrone 3-O-sulphamate, a highly potent steroid sulphatase inhibitor.
Reed JE; Woo LW; Robinson JJ; Leblond B; Leese MP; Purohit A; Reed MJ; Potter BV
Biochem Biophys Res Commun; 2004 Apr; 317(1):169-75. PubMed ID: 15047163
[TBL] [Abstract][Full Text] [Related]
17. Novel steroid sulfatase inhibitors based on N-thiophosphorylated 3-(4-aminophenyl)-coumarin-7-O-sulfamates.
Daśko M; Demkowicz S; Biernacki K; Harrous A; Rachon J; Kozak W; Martyna A; Masłyk M; Kubiński K; Boguszewska-Czubara A
Drug Dev Res; 2019 Sep; 80(6):857-866. PubMed ID: 31301181
[TBL] [Abstract][Full Text] [Related]
18. Aromatase and dual aromatase-steroid sulfatase inhibitors from the letrozole and vorozole templates.
Wood PM; Woo LW; Thomas MP; Mahon MF; Purohit A; Potter BV
ChemMedChem; 2011 Aug; 6(8):1423-38. PubMed ID: 21608133
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and structure-activity relationship studies of derivatives of the dual aromatase-sulfatase inhibitor 4-{[(4-cyanophenyl)(4H-1,2,4-triazol-4-yl)amino]methyl}phenyl sulfamate.
Woo LW; Wood PM; Bubert C; Thomas MP; Purohit A; Potter BV
ChemMedChem; 2013 May; 8(5):779-99. PubMed ID: 23495205
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of MCF-7 breast cancer cell proliferation and in vivo steroid sulphatase activity by 2-methoxyoestradiol-bis-sulphamate.
Raobaikady B; Purohit A; Chander SK; Woo LW; Leese MP; Potter BV; Reed MJ
J Steroid Biochem Mol Biol; 2003 Feb; 84(2-3):351-8. PubMed ID: 12711022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
